# Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease

> **NCT04912323** · NA · RECRUITING · sponsor: **R3 Vascular Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Peripheral Arterial Disease
- Atherosclerotic Lesion
- Lower Extremity Ischemia
- Lower Extremity Claudication

## Interventions

- **DEVICE:** Percutaneous Implantation of the MAGNITUDE® Bioresorbable Arterial Scaffold

## Key facts

- **NCT ID:** NCT04912323
- **Lead sponsor:** R3 Vascular Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-17
- **Primary completion:** 2026-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04912323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04912323, "Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT04912323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*